Tango Therapeutics (TNGX) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 9:00 A.M. Eastern Time on June 4, 2026, and conducted virtually to increase inclusivity among stockholders.

• The agenda included conducting business first, followed by a Q&A session after proposal presentations.

Board and executive committee updates

• Introductions were made for outside directors and key management, including the CEO, CFO, President of R&D, and VP Legal.

• Broadridge Financial Solutions acted as tabulator, and an Independent Inspector of Elections was appointed.

Shareholder proposals

• Three proposals were presented: election of Class II directors, ratification of the independent auditor, and an advisory vote on executive compensation.

• Votes for a resigned director nominee were disregarded.